Literature DB >> 8874190

Shear-dependent changes in the three-dimensional structure of human von Willebrand factor.

C A Siedlecki1, B J Lestini, K K Kottke-Marchant, S J Eppell, D L Wilson, R E Marchant.   

Abstract

The three-dimensional tertiary structure of human von Willebrand Factor (vWF) on a hydrophobic surface under aqueous conditions and different shear stress regimes was studied by atomic force microscopy (AFM). vWF was imaged by AFM at molecular level resolution under negligible shear stress, under a local applied shear force (7.4 to 19 nN) using the AFM probe in contact mode scanning, and after subjecting vWF to a range of shear stress (0 to 42.4 dyn/cm2) using a rotating disk system. The results demonstrate that vWF undergoes a shear stress-induced conformational transition from a globular state to an extended chain conformation with exposure of intra-molecular globular domains at a critical shear stress of 35 +/- 3.5 dyn/cm2. The globular vWF conformation (149 nm by 77 nm and height 3.8 nm) is representative of native vWF after simple diffusion to the hydrophobic surface, followed by adhesion and some spreading. In a shear stress field above the critical value, protein unfolding occurs and vWF is observed in extended chain conformations oriented in the direction of the shear stress field with molecular lengths ranging from 146 to 774 nm and 3.4 nm mean height. The shear stress-induced structural changes to vWF suggest a close conformation-function relationship in vWF properties for thrombogenesis in regions of high shear stress.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8874190

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  152 in total

1.  The role of von Willebrand factor and ADAMTS13 in the no-reflow phenomenon: after primary percutaneous coronary intervention.

Authors:  Bilian Zhao; Jian Li; Xinping Luo; Qing Zhou; Hua Chen; Haiming Shi
Journal:  Tex Heart Inst J       Date:  2011

Review 2.  Arterial thrombosis--insidious, unpredictable and deadly.

Authors:  Shaun P Jackson
Journal:  Nat Med       Date:  2011-11-07       Impact factor: 53.440

3.  The mechanism of VWF-mediated platelet GPIbalpha binding.

Authors:  Matthew Auton; Cheng Zhu; Miguel A Cruz
Journal:  Biophys J       Date:  2010-08-09       Impact factor: 4.033

4.  Platelets, glycoprotein Ib-IX, and von Willebrand factor are required for FeCl(3)-induced occlusive thrombus formation in the inferior vena cava of mice.

Authors:  M V Joglekar; Jerry Ware; Jin Xu; Malinda E C Fitzgerald; Theodore Kent Gartner
Journal:  Platelets       Date:  2012-06-21       Impact factor: 3.862

5.  The ADAMTS13 metalloprotease domain: roles of subsites in enzyme activity and specificity.

Authors:  Rens de Groot; David A Lane; James T B Crawley
Journal:  Blood       Date:  2010-07-20       Impact factor: 22.113

6.  Characterizing Single-Molecule Conformational Changes Under Shear Flow with Fluorescence Microscopy.

Authors:  Yi Wang; Megan E Blauch; Avani V Pisapati; Nathan J Wittenberg; Xuanhong Cheng; X Frank Zhang
Journal:  J Vis Exp       Date:  2020-01-25       Impact factor: 1.355

7.  Von Willlebrand adhesion to surfaces at high shear rates is controlled by long-lived bonds.

Authors:  Charles E Sing; Jennifer G Selvidge; Alfredo Alexander-Katz
Journal:  Biophys J       Date:  2013-09-17       Impact factor: 4.033

8.  Antibodies to von Willebrand factor-cleaving protease in acute thrombotic thrombocytopenic purpura.

Authors:  H M Tsai; E C Lian
Journal:  N Engl J Med       Date:  1998-11-26       Impact factor: 91.245

Review 9.  Diverse activities of von Willebrand factor in traumatic brain injury and associated coagulopathy.

Authors:  Xin Xu; Rosemary Kozar; Jianning Zhang; Jing-Fei Dong
Journal:  J Thromb Haemost       Date:  2020-10-06       Impact factor: 5.824

Review 10.  Catch-bond mechanism of force-enhanced adhesion: counterintuitive, elusive, but ... widespread?

Authors:  Evgeni V Sokurenko; Viola Vogel; Wendy E Thomas
Journal:  Cell Host Microbe       Date:  2008-10-16       Impact factor: 21.023

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.